» Articles » PMID: 16023972

Natural History of Hepatitis C

Overview
Journal Clin Liver Dis
Specialty Gastroenterology
Date 2005 Jul 19
PMID 16023972
Citations 145
Authors
Affiliations
Soon will be listed here.
Abstract

Fifteen years after the discovery of the hepatitis C virus, a substantial amount of information has been learned about the natural history of infection. Testing for viral nucleic acid made it possible to accurately diagnose chronic infection and provided a more precise estimate of the overall frequency of viral persistence. Although cirrhosis and hepatocellular carcinoma can arise in persons with chronic hepatitis C, these outcomes do not always occur. The cirrhosis risk is greater in those who are infected at older ages, those who drink >50 g of alcohol each day, and persons coinfected with HIV. However, much of the person-to-person variability in progression of chronic hepatitis C remains unexplained. The ability to detect persons at highest risk of progression remains incomplete and represents an important future challenge in the understanding of the natural history of hepatitis C.

Citing Articles

Pharmacokinetics of Sofosbuvir/Velpatasvir and efficacy of an alternate-day treatment in hemodialysis patients with chronic hepatitis C infection.

Chariyavilaskul P, Prompila N, Wittayalertpanya S, Lekhyananda S, Prasithsirikul W, Trakarnvanich T Clin Transl Sci. 2024; 17(7):e13884.

PMID: 39004798 PMC: 11246974. DOI: 10.1111/cts.13884.


Markers of Natural Killer Cell Exhaustion in HIV/HCV Coinfection and Their Dynamics After HCV Clearance Mediated by Direct-Acting Antivirals.

Osegueda A, Polo M, Baquero L, Urioste A, Ghiglione Y, Paz S Open Forum Infect Dis. 2023; 10(12):ofad591.

PMID: 38107019 PMC: 10723816. DOI: 10.1093/ofid/ofad591.


Exposure to Agent Orange and Hepatocellular Carcinoma Among US Military Personnel.

Benhammou J, Leng M, Shah S, Cholankeril G, Dong T, Patel A JAMA Netw Open. 2023; 6(12):e2346380.

PMID: 38048128 PMC: 10696483. DOI: 10.1001/jamanetworkopen.2023.46380.


Temporal Trends in Hepatitis C-Related Hospitalizations, United States, 2000-2019.

Hofmeister M, Zhong Y, Moorman A, Samuel C, Teshale E, Spradling P Clin Infect Dis. 2023; 77(12):1668-1675.

PMID: 37463305 PMC: 11017377. DOI: 10.1093/cid/ciad425.


Evaluating the utility of a two-assay serological algorithm for hepatitis C screening in a low prevalence population.

Rogers K, Halvorson T, Krasowski M, Merrill A J Clin Lab Anal. 2023; 37(7):e24887.

PMID: 37106580 PMC: 10220299. DOI: 10.1002/jcla.24887.